Group One Trading
ALXA

Group One Trading’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Group One Trading’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-134,800
Closed -$585K – 5912
2013
Q2 		$585K Buy
+134,800
New +$611K 0.01% 1217

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Group One Trading's ALXA Position: Q1 2015 in Review

Group One Trading sold out of Alexza Pharmaceuticals Inc (ALXA) in Q1 2015, closing a stake of 20,875 shares — an estimated $31K sold.

Group One Trading first reported a position in ALXA in Q3 2013 and held it in 6 quarters. The position peaked at $431K in Q4 2013. 28 funds tracked by Wall St. Rank hold ALXA as of Q1 2015.

  • Group One Trading reported no remaining Alexza Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Group One Trading sold 20,875 Alexza Pharmaceuticals Inc shares in Q1 2015, an estimated $31K.
  • Group One Trading first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 6 quarters.
  • Group One Trading's Alexza Pharmaceuticals Inc position peaked at $431K in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q1 2015.

Based on Group One Trading's 13F filing for Q1 2015, filed 14 May 2015.